Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, L.P.

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. LMT
8. USO
9. META
10. TLT

Go back to Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, L.P.

Ascendis Pharma (ASND) PT Lowered to $200 at Citi

November 15, 2024 7:10 AM EST

Citi analyst David Lebowitz lowered the price target on Ascendis Pharma (NASDAQ: ASND) to $200.00 (from $207.00) while maintaining a Buy rating.

The analyst comments "Ascendis reported 3Q24 financial results, missing Street estimates on topline revenue and GAAP EPS, as the Skytrofa challenges that emerged... More

Ascendis Pharma (ASND) PT Lowered to $180 at Oppenheimer

November 15, 2024 6:21 AM EST

Oppenheimer analyst Leland Gershell lowered the price target on Ascendis Pharma (NASDAQ: ASND) to $180.00 (from $190.00) while maintaining a Outperform rating.

The analyst comments "ASND reported 3Q net loss of 99.2M vs. our expected 110.2M as management continues to effectively manage expenses. Skytrofa revenue of... More